Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Hong Kong · Delayed Price · Currency is HKD 7.71
-0.07 (-0.90%)
At close: Mar 27, 2026
HKG:3613 Revenue
In the year 2025, Beijing Tong Ren Tang Chinese Medicine Company had annual revenue of 1.51B HKD, down -6.10%. Beijing Tong Ren Tang Chinese Medicine Company had revenue of 751.62M in the half year ending December 31, 2025, with 5.54% growth.
Revenue
1.51B
Revenue Growth
-6.10%
P/S Ratio
4.26
Revenue / Employee
1.94M
Employees
789
Market Cap
6.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.51B | -98.29M | -6.10% |
| Dec 31, 2024 | 1.61B | 86.70M | 5.69% |
| Dec 31, 2023 | 1.52B | -206.15M | -11.91% |
| Dec 31, 2022 | 1.73B | 174.94M | 11.24% |
| Dec 31, 2021 | 1.56B | 240.81M | 18.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Traditional Chinese Medicine Holdings Co. | 16.41B |
| Shandong Xinhua Pharmaceutical Company | 9.28B |
| Luye Pharma Group | 6.76B |
| SSY Group | 4.17B |
| China Shineway Pharmaceutical Group | 3.49B |
| Sihuan Pharmaceutical Holdings Group | 2.30B |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 763.16M |
| CF PharmTech | 647.51M |